Hiroki Asano

802 total citations
44 papers, 630 citations indexed

About

Hiroki Asano is a scholar working on Biomedical Engineering, Oncology and Epidemiology. According to data from OpenAlex, Hiroki Asano has authored 44 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 8 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Hiroki Asano's work include Acoustic Wave Resonator Technologies (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Mechanical and Optical Resonators (5 papers). Hiroki Asano is often cited by papers focused on Acoustic Wave Resonator Technologies (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Mechanical and Optical Resonators (5 papers). Hiroki Asano collaborates with scholars based in Japan, Tanzania and Germany. Hiroki Asano's co-authors include Ken‐ya Hashimoto, Yohei Kanamori, Tatsuya Omori, Masayuki Funaba, Masatsune Yamaguchi, Tohru Matsui, N. Takenaka, Takayuki Nara, Satoshi Higurashi and Ken Kato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Endocrinology.

In The Last Decade

Hiroki Asano

41 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Asano Japan 14 170 150 103 103 92 44 630
Hao‐Chang Hung Taiwan 17 56 0.3× 139 0.9× 79 0.8× 49 0.5× 206 2.2× 48 878
Ji Hyun Kang South Korea 12 118 0.7× 38 0.3× 89 0.9× 58 0.6× 154 1.7× 33 630
Akihiro Kojima Japan 15 163 1.0× 90 0.6× 50 0.5× 36 0.3× 22 0.2× 71 856
C. Bock United States 13 252 1.5× 119 0.8× 46 0.4× 39 0.4× 63 0.7× 21 857
Hongyu Li China 13 167 1.0× 36 0.2× 53 0.5× 66 0.6× 46 0.5× 43 638
Masafumi Kubota Japan 20 201 1.2× 81 0.5× 100 1.0× 34 0.3× 123 1.3× 104 1.3k
Hiroyuki Hara Japan 17 98 0.6× 103 0.7× 61 0.6× 28 0.3× 51 0.6× 91 944
José Ricardo de Arruda Miranda Brazil 23 447 2.6× 160 1.1× 75 0.7× 20 0.2× 60 0.7× 107 1.3k
Ci Song China 16 214 1.3× 93 0.6× 20 0.2× 67 0.7× 29 0.3× 47 750
Joowon Lee United States 17 85 0.5× 239 1.6× 167 1.6× 73 0.7× 190 2.1× 47 1.4k

Countries citing papers authored by Hiroki Asano

Since Specialization
Citations

This map shows the geographic impact of Hiroki Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Asano more than expected).

Fields of papers citing papers by Hiroki Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Asano. The network helps show where Hiroki Asano may publish in the future.

Co-authorship network of co-authors of Hiroki Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Asano. A scholar is included among the top collaborators of Hiroki Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Asano. Hiroki Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Noguchi, Yoshihiro, et al.. (2024). Association between CDK4/6 inhibitors and drug‐related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System. International Journal of Cancer. 155(5). 849–853. 6 indexed citations
3.
Noguchi, Yoshihiro, et al.. (2024). Relationship between Anaplastic Lymphoma Kinase Inhibitors and Epileptic Seizure Disorder: A Post-Marketing Surveillance Study. Oncology. 102(11). 996–1003. 1 indexed citations
5.
Asano, Hiroki, Yoshihiro Noguchi, Michio Kimura, Eiseki Usami, & Tomoaki Yoshimura. (2023). Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database. Medicina. 59(11). 1963–1963. 2 indexed citations
6.
Asano, Hiroki, Taku Nagai, Takao Kohno, et al.. (2021). Microinjection of Reelin into the mPFC prevents MK-801-induced recognition memory impairment in mice. Pharmacological Research. 173. 105832–105832. 17 indexed citations
7.
Asano, Hiroki, et al.. (2021). The Effect of Diquafosol Ophthalmic Solution on Clinical Parameters and Visual Function in Soft Contact Lens-Related Dry Eye. Advances in Therapy. 38(11). 5534–5547. 8 indexed citations
8.
Asano, Hiroki, et al.. (2019). Distribution of corneal spherical aberration in a Tanzanian population. PLoS ONE. 14(9). e0222297–e0222297. 4 indexed citations
9.
Asano, Hiroki, et al.. (2018). Efficacy and safety of diquafosol ophthalmic solution for soft contact lens-related dry eye. Investigative Ophthalmology & Visual Science. 59(9). 1788–1788. 1 indexed citations
10.
Usami, Eiseki, et al.. (2016). [Treatment Continuation and Safety of Eribulin for the Treatment of Metastatic Breast Cancer].. PubMed. 43(13). 2513–2516. 1 indexed citations
11.
Kimura, Michio, et al.. (2016). Potential drug interaction between paclitaxel and clopidogrel. Biomedical Reports. 5(1). 141–145. 6 indexed citations
12.
Kanamori, Yohei, Hiroki Asano, Osamu Hashimoto, et al.. (2013). Regulation of brown adipogenesis by the Tgf-β family: Involvement of Srebp1c in Tgf-β- and Activin-induced inhibition of adipogenesis. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(11). 5027–5035. 24 indexed citations
13.
Asano, Hiroki, Yohei Kanamori, Masaru Murakami, et al.. (2013). Bmp4 expressed in preadipocytes is required for the onset of adipocyte differentiation. Cytokine. 64(1). 138–145. 27 indexed citations
14.
Asano, Hiroki, Tomoya Yamada, Osamu Hashimoto, et al.. (2013). Diet-induced changes in Ucp1 expression in bovine adipose tissues. General and Comparative Endocrinology. 184. 87–92. 33 indexed citations
15.
Kaku, Hiroto, et al.. (2012). Calorimetric study and simulation of the adsorption of methanol and propanol onto activated carbon fibers. Colloids and Surfaces A Physicochemical and Engineering Aspects. 419. 100–112. 9 indexed citations
16.
Yoneda, Takeshi, Hiroki Asano, Takafumi Mizushige, et al.. (2009). Assessing palatability of long-chain fatty acids from the licking behavior of BALB/c mice. Physiology & Behavior. 96(4-5). 735–741. 14 indexed citations
17.
Kaji, Yuichi, Takahiro Hiraoka, Fumiki Okamoto, Hiroki Asano, & Tetsuro Oshika. (2007). Comparison of triamcinolone acetonide, 11‐deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models. Acta Ophthalmologica. 86(1). 97–102. 4 indexed citations
18.
Hashimoto, Ken‐ya, et al.. (2005). Wideband love wave filters operating in GHz range on Cu-grating/rotated-YX-LiNbO/sub 3/-substrate structure. 2. 1330–1334. 39 indexed citations
19.
Asano, Hiroki, et al.. (2004). Visualization and void fraction measurement of gas–liquid two-phase flow in plate heat exchanger. Applied Radiation and Isotopes. 61(4). 707–713. 11 indexed citations
20.
Hashimoto, Ken‐ya, Hiroki Asano, T. Omori, & M. Yamaguchi. (2004). Ultra wideband love wave devices employing cu-grating/rotated YX LiNbO/sub 3/-substrate structure. 2. 917–920. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026